Nath Bio-Genes (India) Share Price: What Could the Next 3 Years Look Like?

The Nath Bio-Genes (India) share price forecast for the next 3 years is a question on many investors' minds as the stock trades at Rs 164, within a 52 week range of Rs 126 to Rs 207. This article lays out a scenario based Nath Bio-Genes (India) share price outlook for 2027, 2028 and 2030, built on the company's fundamentals, sector trends and the key risks that could change the trajectory. Rather than a single number, the focus here is on the range of outcomes and the assumptions behind each one.

Click Here – Get Free Investment Predictions

Nath Bio-Genes (India) Company Overview

Nath Bio-Genes develops and markets hybrid seeds for cotton, corn and other crops to Indian farmers through its research and distribution network. Understanding the business model is the first step in framing any credible Nath Bio-Genes (India) share price forecast, because the durability of earnings ultimately decides where the stock trades.

Company	Nath Bio-Genes (India)
NSE Ticker	NATHBIOGEN
CMP	Rs 164
52 Week High	Rs 207
52 Week Low	Rs 126
Market Cap	Rs 313 Cr
Stock PE	8.64
Book Value	Rs 358
ROE	5.47%
ROCE	7.1%
Dividend Yield	1.21%

Where Does Nath Bio-Genes (India) Share Price Stand Today?

The stock currently trades about 21 percent below its 52 week high of Rs 207, which means the market has already tempered some of its optimism. For anyone building a Nath Bio-Genes (India) share price forecast, this correction matters for the Nath Bio-Genes (India) share price forecast starting point, because entry valuations have a large bearing on 3 year returns.

At the current price, Nath Bio-Genes (India) commands a market capitalisation of Rs 313 Cr and trades at a price to earnings multiple of 8.64. The company generates a return on equity of 5.47% and a return on capital employed of 7.1%, which places it in the category of businesses with a recovering profitability profile. These numbers anchor the Nath Bio-Genes (India) share price forecast scenarios that follow. How the broader Nifty 50 index trades over this period will also influence the multiple investors are willing to assign to the stock.

Nath Bio-Genes (India) Share Price Forecast: Key Growth Drivers for the Next 3 Years

Four forces are likely to shape the Nath Bio-Genes (India) share price forecast between now and 2030, and together they explain most of the dispersion in this Nath Bio-Genes (India) share price forecast. Each is discussed below with its likely direction of impact.

Earnings Trajectory and Return Ratios

Stock prices ultimately follow earnings. With a recovering profitability profile at present, the pace at which profits compound over FY27 to FY30 will be the single biggest determinant of the Nath Bio-Genes (India) share price forecast actually playing out. Consistent earnings delivery tends to expand valuation multiples, while misses compress them quickly.

Aquaculture and Agri Export Opportunities

Global protein demand and India's competitiveness in aquaculture support long term export growth. Integrated players like Nath Bio-Genes (India) with feed leadership and processing scale benefit most when the cycle turns favourable.

Within the space, investors often benchmark Nath Bio-Genes (India) against peers such as Kaveri Seed Company, Indo Us Biotech and Bombay Super Hybrid Seeds on growth and valuations before forming a view on the Nath Bio-Genes (India) share price forecast.

Company Specific Catalysts

The bull case for Nath Bio-Genes (India) rests on rising adoption of hybrid seed varieties among Indian farmers and expansion of its research pipeline. If these play out on schedule, the Nath Bio-Genes (India) share price forecast for 2030 could gravitate toward the upper end of the scenario range discussed below.

Macro Environment and Liquidity

The RBI rate cycle, FII flows into Indian equities and overall market valuations will influence the multiple investors are willing to pay. A benign macro backdrop supports the optimistic end of any Nath Bio-Genes (India) share price forecast, while global risk aversion would do the opposite to the Nath Bio-Genes (India) share price outlook.

Nath Bio-Genes (India) Share Price Forecast 2027, 2028 and 2030: Scenario Analysis

The table below presents a scenario based Nath Bio-Genes (India) share price forecast using compounded annual growth assumptions applied to the current market price of Rs 164. These are illustrative ranges, not point predictions, and actual outcomes can fall outside them.

Year	Bear Case	Base Case	Bull Case	Assumption
2027	Rs 170	Rs 185	Rs 200	2% to 14% CAGR on CMP
2028	Rs 170	Rs 200	Rs 225	2% to 14% CAGR on CMP
2030	Rs 180	Rs 230	Rs 295	2% to 14% CAGR on CMP

In the base case scenario of this Nath Bio-Genes (India) share price forecast, the 2030 level works out to roughly Rs 230, implying steady compounding from today's levels. The bull case of Rs 295 assumes rising adoption of hybrid seed varieties among Indian farmers and expansion of its research pipeline delivers ahead of expectations, while the bear case of Rs 180 captures a scenario where growth stalls. That is an outcome band of about 10 percent to 80 percent over the period.

Consult a SEBI Registered Investment Advisor Before Acting on Any Forecast

Bull Case vs Bear Case for Nath Bio-Genes (India) Share Price

The Bull Case

The optimistic Nath Bio-Genes (India) share price forecast assumes rising adoption of hybrid seed varieties among Indian farmers and expansion of its research pipeline. Combined with supportive sector conditions, this could lift both earnings and the valuation multiple, pushing the stock toward Rs 295 by 2030.

The Bear Case

The cautious view centres on the fact that monsoon dependent demand and regulatory approval timelines for new seed varieties are key risks. If these pressures dominate, the Nath Bio-Genes (India) share price forecast would skew toward the lower band and the stock could stagnate near Rs 180 even by 2030, underperforming broader indices.

Key Risks That Could Change the Nath Bio-Genes (India) Share Price Outlook

• Execution risk: Delays in strategy execution or capacity plans would push the earnings trajectory below the base case assumed in this Nath Bio-Genes (India) share price forecast.
• Valuation risk: At a PE of 8.64, any earnings disappointment can trigger sharp multiple compression before fundamentals stabilise.
• Sector risk: Monsoon dependent demand and regulatory approval timelines for new seed varieties are key risks.
• Macro risk: A global slowdown, adverse FII flows or unexpected rate moves would compress equity valuations across the market.
• Regulatory risk: Policy, tax or compliance changes affecting the sector can alter the earnings outlook with little warning.

Is Nath Bio-Genes (India) Worth Watching for the Long Term?

For long term investors, the relevant question is not just where the Nath Bio-Genes (India) share price forecast lands in 2030 or what any single Nath Bio-Genes (India) share price forecast says today, but whether the business can compound capital through cycles. The company's positioning around rising adoption of hybrid seed varieties among Indian farmers and expansion of its research pipeline gives it a credible growth story, while the risks outlined above define what must be monitored each quarter.

Investors should track quarterly earnings, management commentary and sector data rather than anchoring to any single number from a Nath Bio-Genes (India) share price outlook. Historically, staying focused on business fundamentals has served investors better than chasing price targets, and consulting a SEBI registered advisor before investing remains the prudent approach.

Download the Univest iOS App or Univest Android App to track Nath Bio-Genes (India) share price live.

Conclusion

The Nath Bio-Genes (India) share price forecast for the next 3 years spans Rs 180 to Rs 295 by 2030 under the scenarios discussed, with a base case near Rs 230. Any credible Nath Bio-Genes (India) share price forecast must be updated as facts change, and the path will be decided by earnings delivery, rising adoption of hybrid seed varieties among Indian farmers and expansion of its research pipeline and the broader market environment. Treat these ranges as a framework for thinking, not a promise of outcomes, and revisit the assumptions as new results come in. Consult a SEBI registered investment advisor before making any investment decision.

What is the Nath Bio-Genes (India) share price forecast for the next 3 years?

Ans. The Nath Bio-Genes (India) share price forecast for the next 3 years is scenario based rather than a single number. By 2030, the illustrative range spans Rs 180 in the bear case to Rs 295 in the bull case, with a base case near Rs 230, depending on earnings delivery and market conditions.

What is the Nath Bio-Genes (India) share price forecast for 2027?

Ans. For 2027, the scenario range works out to Rs 170 to Rs 200, with a base case around Rs 185. This assumes compounding on the current price of Rs 164 and is illustrative, not a guaranteed outcome.

What is the Nath Bio-Genes (India) share price forecast for 2028?

Ans. The 2028 scenario range is Rs 170 to Rs 225, with the base case near Rs 200. Actual levels will depend on earnings growth, sector trends and overall market valuations at the time.

What is the current share price of Nath Bio-Genes (India)?

Ans. Nath Bio-Genes (India) currently trades at around Rs 164 on the NSE, within a 52 week range of Rs 126 to Rs 207. Prices change continuously during market hours, so check live quotes before acting.

Is Nath Bio-Genes (India) a good stock for the long term?

Ans. Nath Bio-Genes (India) has a credible long term story built on rising adoption of hybrid seed varieties among Indian farmers and expansion of its research pipeline, but it also carries risks since monsoon dependent demand and regulatory approval timelines for new seed varieties are key risks. Long term suitability depends on your risk profile and portfolio, so consult a SEBI registered investment advisor before investing.

What is the Nath Bio-Genes (India) share price outlook for 2030?

Ans. The Nath Bio-Genes (India) share price outlook for 2030 spans Rs 180 to Rs 295 across bear and bull scenarios. Where the stock actually lands will be driven by profit growth, valuation multiples and macro conditions closer to that date.

What are the key risks to the Nath Bio-Genes (India) share price forecast?

Ans. The main risks are execution delays, valuation compression from the current PE of 8.64, sector specific pressures, macro shocks and regulatory changes. Any of these can push the stock below the base case scenario discussed in this article.